AFFLUENCE

Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Aakaar Medical Technologies Ltd. announces H2 & FY2025-26 ResultsStrongest H2 - Delivered as promised; Impact of tightened and disciplined financial approach".

Submission of certificate of extinguishment of 5423728 equity shares of Re.1/- of the Company bought back from the shareholders of the Company under Buyback Offer.

Blue Pebble Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Inter alia, approved:- 1. Recommended a final Dividend of Rs.5/- (i.e 50 %) per equity share of Rs.10/- each on the fully paid-up equity share capital of the Company which is subject to approval of Shareholders in the ensuing Annual General Meeting of the Company. The Dividend will be paid within 30 days from the date of Shareholders approval in the ensuing Annual General Meeting of the Company. 2. Based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company approved the allotment of 18,033 equity shares to those employees who have exercised their options for equity shares under the Centum - Restricted Stock Unit Plan 2021. The paid-up equity share capital of the Company has increased from Rs. 14,74,09,830 /- to Rs. 14,75,90,160 /- due to the aforesaid allotment. 3. Re-appointment of the Auditor(s) The Board of Directors on the recommendation of Audit Committee have approved the reappointment of following Auditors for the Financial Year 2026-27: ? KPMG Assurance and Consulting Services, LLP as Internal Auditor. ? M/s. K.S. Kamalakara & Co., Cost Accountants (Registration No. 000296) as the Cost Auditors. 4. The Board of Directors on the recommendation of Audit Committee has considered and approved the amendments to the Policy on Related Party Transactions.

inter alia, considered and approved the following: 1) Recommendation for Appointment and regularization of Mr. Vikkas Bansal (DIN: 00441630) as Chairman and Managing Director of the Company subject to the approval of members. 2) Recommendation for regularization of Mr. Tarun Jain (DIN: 09199801) as Executive Director of the Company subject to the approval of members. 3) Recommendation for regularization of Mr. Tarun Jain (DIN: 09199801) as Executive Director of the Company subject to the approval of members. 4) Recommendation for regularization of Mr. Maneesh Gupta (DIN: 00129254) as Independent Director of the Company subject to the approval of members. 5) Recommendation for regularization of Mr. Sushil Aggarwal (DIN: 07194474) as Independent Director of the Company subject to the approval of members. 6) Recommendation for regularization of Ms. Sathi Kundu (DIN: 10837461) as a Woman Independent Director of the Company subject to the approval of members. 7) Adoption of Constitutional documents i.e. Memorandum of Association (MOA) and Articles of Association (AOA) of the Company as per Companies Act, 2013 subject to the approval of members. 8) Issue of 47,17,740 (Forty-Seven Lakh Seventeen Thousand Seven Hundred and Forty) equity shares on preferential basis to the persons belonging to ?Non-promoter, Public category? subject to the approval of members. (refer enclosed Annexure-A). 9) Increase in Authorised Share Capital of Company by amending the Memorandum of Association (?MOA?) of Company subject to the approval of members